Six months after his surprise appointment as CEO, Attila Vegh has left Capio, the Nordic acute care group that is now part of Australian-owned French hospital group Ramsay Generale de Sante following its acquisition in Q4 2018.
German dialysis, hospital, rehab and pharma group Fresenius has seen its share price fall 15% after it cut its medium-term guidance, owing to lower profit expectations at its dialysis and hospital businesses.
Insurers and big occupational healthcare providers are sceptical about a new generation of lifestyle genetic testing linked to apps which are designed to enable individuals to achieve higher levels of wellness. But they are starting to deploy more specific tests that diagnose rare diseases. We talk to major operators and insurers about how they see the genetic test market.
DomusVi's Aymar Hénin is quitting as President, despite the company's recent acquisition spree. Puzzlingly, the company says he quit on November 7 but has yet to make a public announcement despite having a large bond issue outstanding.
Pan-Asian hospital operator IHH is likely to float SRL, the diagnostics arm of troubled hospital chain Fortis, next year, according to some local reports - but Healthcare Nova has heard different.
A public consultation on competition in South Africa could lead to a relaxation on external investment in the laboratory market, Healthcare Nova hears.
The number of people who are covered by private health insurance has largely risen across Europe in the past decade, according to a report by the OECD.
A senior official at pan-Asian hospital group IHH has said that it will likely scrap the branding of troubled hospital company Fortis once litigation is over.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.